Drug tolerance to KRAS inhibition remains a major challenge in cancer therapy. Here the authors find that KRAS inhibition induces a cellular state characterized by enhanced ribosome biogenesis in KRAS-mutant colorectal cancer cells and these cells are vulnerable to inhibition of RNA polymerase I.
- Yui Tanaka
- Mizuho Sakahara
- Ryoji Yao